Home/Pipeline/Neurodegenerative Disease Assays (GFAP, NfL, pTau-217)

Neurodegenerative Disease Assays (GFAP, NfL, pTau-217)

Neurology / Alzheimer's Disease Research

Assay Menu ExpansionActive

Key Facts

Indication
Neurology / Alzheimer's Disease Research
Phase
Assay Menu Expansion
Status
Active
Company

About Beckman Coulter Diagnostics

Beckman Coulter Diagnostics, a Danaher company, is a premier provider of in-vitro diagnostic (IVD) systems, instruments, and reagents for clinical laboratories globally. Its mission is to deliver actionable diagnostic insights through a deeply integrated portfolio spanning chemistry, immunoassay, hematology, and workflow informatics. The company's strategy is anchored in continuous innovation within its core lab franchises, expansion into high-growth areas like sepsis management and digital hematology, and the relentless operational discipline of the Danaher Business System.

View full company profile